These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Clinicopathologic Analysis of Angioimmunoblastic T-cell Lymphoma With or Without RHOA G17V Mutation Using Formalin-fixed Paraffin-embedded Sections. Nagao R; Kikuti YY; Carreras J; Kikuchi T; Miyaoka M; Matsushita H; Kojima M; Ando K; Sakata-Yanagimoto M; Chiba S; Nakamura N Am J Surg Pathol; 2016 Aug; 40(8):1041-50. PubMed ID: 27158755 [TBL] [Abstract][Full Text] [Related]
6. Angioimmunoblastic T-cell lymphoma in Taiwan reveals worse progression-free survival for Hsu YT; Wang YC; Chen RY; Hung LY; Li SS; Yen CC; Chen TY; Medeiros LJ; Chang KC Leuk Lymphoma; 2020 May; 61(5):1108-1118. PubMed ID: 31870198 [TBL] [Abstract][Full Text] [Related]
7. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR. Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466 [TBL] [Abstract][Full Text] [Related]
8. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970 [TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL. Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798 [TBL] [Abstract][Full Text] [Related]
10. Expression of TFH Markers and Detection of RHOA p.G17V and IDH2 p.R172K/S Mutations in Cutaneous Localizations of Angioimmunoblastic T-Cell Lymphomas. Leclaire Alirkilicarslan A; Dupuy A; Pujals A; Parrens M; Vergier B; Robson A; Delfau-Larue MH; Ingen-Housz-Oro S; Chosidow O; Haioun C; Beylot-Barry M; Merlio JP; Copie-Bergman C; Gaulard P; Ortonne N Am J Surg Pathol; 2017 Dec; 41(12):1581-1592. PubMed ID: 28945625 [TBL] [Abstract][Full Text] [Related]
11. Parallel evolution of two distinct lymphoid proliferations in clonal haematopoiesis. Attygalle AD; Dobson R; Chak PK; Vroobel KM; Wren D; Mugalaasi H; Morgan Y; Kaur M; Ahmad R; Chen Z; Naresh KN; Du MQ Histopathology; 2022 Apr; 80(5):847-858. PubMed ID: 35064935 [TBL] [Abstract][Full Text] [Related]
12. Activation of RHOA-VAV1 signaling in angioimmunoblastic T-cell lymphoma. Fujisawa M; Sakata-Yanagimoto M; Nishizawa S; Komori D; Gershon P; Kiryu M; Tanzima S; Fukumoto K; Enami T; Muratani M; Yoshida K; Ogawa S; Matsue K; Nakamura N; Takeuchi K; Izutsu K; Fujimoto K; Teshima T; Miyoshi H; Gaulard P; Ohshima K; Chiba S Leukemia; 2018 Mar; 32(3):694-702. PubMed ID: 28832024 [TBL] [Abstract][Full Text] [Related]
13. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis. Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366 [TBL] [Abstract][Full Text] [Related]
14. TET-2 mutations predict poor outcomes and are associated with unfavorable clinical-biological features in PTCL, not otherwise specified and angioimmunoblastic T-cell lymphoma in Brazilian patients. de Pádua Covas Lage LA; Barreto GC; Culler HF; Cavalcante JB; de Oliveira Alves LB; Nardinelli L; Bendit I; Zerbini MCN; Rocha V; Pereira J Cancer Biomark; 2022; 35(2):179-191. PubMed ID: 36093687 [TBL] [Abstract][Full Text] [Related]
15. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers]. Sakata-Yanagimoto M Rinsho Ketsueki; 2019; 60(9):1221-1228. PubMed ID: 31597847 [TBL] [Abstract][Full Text] [Related]
16. Que F; Zhang L; Wang T; Xu M; Li W; Zang S Oncoimmunology; 2022; 11(1):2134536. PubMed ID: 36249275 [TBL] [Abstract][Full Text] [Related]
17. RHOA G17V Induces T Follicular Helper Cell Specification and Promotes Lymphomagenesis. Cortes JR; Ambesi-Impiombato A; Couronné L; Quinn SA; Kim CS; da Silva Almeida AC; West Z; Belver L; Martin MS; Scourzic L; Bhagat G; Bernard OA; Ferrando AA; Palomero T Cancer Cell; 2018 Feb; 33(2):259-273.e7. PubMed ID: 29398449 [TBL] [Abstract][Full Text] [Related]
18. Combination of multicolor flow cytometry for circulating lymphoma cells and tests for the Hayashida M; Maekawa F; Chagi Y; Iioka F; Kobashi Y; Watanabe M; Ohno H Leuk Lymphoma; 2020 Oct; 61(10):2389-2398. PubMed ID: 32476550 [TBL] [Abstract][Full Text] [Related]
19. G17V RHOA: Genetic evidence of GTP-unbound RHOA playing a role in tumorigenesis in T cells. Chiba S; Enami T; Ogawa S; Sakata-Yanagimoto M Small GTPases; 2015; 6(2):100-3. PubMed ID: 26103434 [TBL] [Abstract][Full Text] [Related]
20. Clonal Hematopoiesis and Bone Marrow Infiltration in Patients With Follicular Helper T-Cell Lymphoma of Angioimmunoblastic Type. Harland L; Borgmann V; Otto F; Overkamp M; Bonzheim I; Fend F; Quintanilla-Martinez L; Nann D Mod Pathol; 2024 Jul; 37(7):100519. PubMed ID: 38777036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]